Management of aromatase inhibitor-associated bone loss (AIBL) in women with hormone-sensitive breast cancer: An updated joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG
Клинические рекомендации
2024
The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)https://www.esceo.org/
Recommendations for the optimal use of bone forming agents in osteoporosis
2024
Global Leadership Initiative In Sarcopenia (GLIS)https://www.esceo.org/glis
The Conceptual Definition of Sarcopenia: Delphi Consensus from the Global Leadership Initiative in Sarcopenia (GLIS)
В разделе Новости опубликован перевод основных положений документа
Развернуть
Свернуть
Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis Foundation (IOF) under the auspices of WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging
2022
American College of Rheumatologyhttps://www.rheumatology.org/
2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Краткое изложение руководство приведено в разделе Новости.
Развернуть
Свернуть
